The effect of sarcopenia on clinical outcome of cirrhotic patients in liver transplantation clinic.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210825008

Enrollment

160

Registered

2021-08-25

Start date

2005-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia and outcome in cirrhosis patient sarcopenia, cirrhosis

Interventions

cirrhosis patients in liver transplant clinic were evaluated for sarcopenia by measuring cross-sectional area of abdominal muscles of L3 level, Cut off below or equal to 52.4 cm per m2 male, and belo

Screening,Screening

sarcopenia,non-sarcopenia

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult > 18-year-old 2. Diagnosis of cirrhosis (Imaging showing cirrhosis or Liver Bx showing cirrhosis) and registered to liver transplant clinic 3. Imaging available (CT or MRI of liver or abdomen)

Exclusion criteria

Exclusion criteria: 1. No imaging (CT or MRI) 2. non-cirrhotic patient (Acute liver failure, acute on top chronic liver failure from any cause, Chronic HBV infection with reactivation without cirrhosis, large hemangioma, amyloidosis, Hepatocellular carcinoma without cirrhosis)

Design outcomes

Primary

Measure	Time frame
sarcopenia mortality 1 year death or not	—

Secondary

Measure	Time frame
non-sarcopenia mortality 1 year death or not	—

Countries

Thailand

Contacts

Public ContactChidkamon Pattarawongpaiboon

King Chulalongkorn Memorial Hospital

chidkamon.p20@chula.md0844099099

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026